Eye scan for surface growths
Part of Cancer, Eyes & vision clinical trials.
This study uses a special eye scan (OCT) to take detailed pictures of growths on the eye's surface. The goal is to see if this scan can help tell which growths are cancerous without needing a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a growth or lesion on the surface of your eye.
- Your doctor suspects the lesion might be cancerous (neoplastic).
- The lesion has not already been confirmed as non-cancerous by a biopsy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a high-resolution scan (called OCT) to better see skin tumors before they’re removed or biopsied. It may help doctors evaluate both non-pigmented and pigmented skin spots that look like possible skin cancer.
This study looks at skin growths near the eye using a special camera. It may help doctors better understand and diagnose these growths without needing a biopsy.
This study uses an imaging scan called optical coherence tomography (a non-painful light scan) during surgery to map what “normal” eye tissue looks like. It may help improve how eye specialists assess eyes in the future.
This study tests a new eye scanner that takes detailed pictures of the back of the eye. It may help doctors see eye problems more clearly and could lead to better care.
This trial tests whether a special eye scan (OCT) can help guide eye surgery during the operation. It may improve how surgeons see and target the exact eye structures they need to treat.
This study uses a simple, painless eye scan (called OCT) to measure the layers at the back of your eyes in people with nearsightedness or farsightedness. The results help doctors better understand normal variations in these measurements for people with different prescriptions.
Hear when a new Ocular Surface Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.